Cargando…

Immune Escape Mechanisms in Non Small Cell Lung Cancer

SIMPLE SUMMARY: Immune escape mechanisms have been identified in every step of lung tumorigenesis. A heterogeneous ensemble of immune evasion processes shapes the evolution of precursor lesions towards the invasive phase, contributes to fostering progression from early stage to metastatic disease an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anichini, Andrea, Perotti, Valentina E., Sgambelluri, Francesco, Mortarini, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761620/ https://www.ncbi.nlm.nih.gov/pubmed/33276569 http://dx.doi.org/10.3390/cancers12123605

Ejemplares similares

An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
por: Perotti, Valentina, et al.
Publicado: (2019)

Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy
por: Anichini, Andrea, et al.
Publicado: (2022)

An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions
por: Anichini, Andrea, et al.
Publicado: (1999)

Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
por: Fucà, Giovanni, et al.
Publicado: (2021)

Sema6A and Mical1 control cell growth and survival of BRAF(V600E) human melanoma cells
por: Loria, Rossella, et al.
Publicado: (2014)

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
por: Tian, Yaru, et al.
Publicado: (2019)

Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation
por: Perotti, V., et al.
Publicado: (2019)

Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma
por: Vandoni, Giulia, et al.
Publicado: (2023)

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
por: Kim, Dong Ha, et al.
Publicado: (2019)

Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
por: GRAZIA, GIULIA, et al.
Publicado: (2014)

Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance
por: Larussa, Tiziana, et al.
Publicado: (2015)

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
por: Tringali, Cristina, et al.
Publicado: (2014)

The microRNA-152/human leukocyte antigen-G axis affects proliferation and immune escape of non-small cell lung cancer cells
por: Fu, Jun, et al.
Publicado: (2020)

IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer
por: Heim, Lisanne, et al.
Publicado: (2022)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
por: Pancione, Massimo, et al.
Publicado: (2014)

The immune phenotypes and different immune escape mechanisms in colorectal cancer
por: Mao, Yihao, et al.
Publicado: (2022)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022)

Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis
por: Huang, Yusheng, et al.
Publicado: (2022)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy
por: Aktar, Nasrin, et al.
Publicado: (2022)

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
por: Grazia, G, et al.
Publicado: (2014)

The Immune Escape Mechanisms of Mycobacterium Tuberculosis
por: Zhai, Weijie, et al.
Publicado: (2019)

Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
por: Kapperman, Heather E., et al.
Publicado: (2018)

Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer
por: Wang, Kaiyuan, et al.
Publicado: (2021)

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
por: Parisi, Claudia, et al.
Publicado: (2020)

Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
por: Onwudiwe, Killian, et al.
Publicado: (2022)

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade
por: Penna, Ilaria, et al.
Publicado: (2015)

Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
por: Zhou, Kexun, et al.
Publicado: (2023)

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
por: Leonetti, Alessandro, et al.
Publicado: (2019)

Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
por: Aramini, Beatrice, et al.
Publicado: (2022)

Advances in research on immune escape mechanism of glioma
por: Guo, Xu, et al.
Publicado: (2023)

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
por: McGranahan, Nicholas, et al.
Publicado: (2017)

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
por: Rice, Shawn J., et al.
Publicado: (2021)

Regulatory T Cells as an Escape Mechanism to the Immune Response in Taenia crassiceps Infection
por: Adalid-Peralta, Laura, et al.
Publicado: (2021)

Feline Coronavirus and Alpha-Herpesvirus Infections: Innate Immune Response and Immune Escape Mechanisms
por: Capozza, Paolo, et al.
Publicado: (2021)

Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression
por: Zhang, Hai, et al.
Publicado: (2020)

New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
por: Jiang, Yi, et al.
Publicado: (2022)

Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface
por: Bruno, Valentina, et al.
Publicado: (2020)

Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
por: Qin, Angel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_id857u02bpt9j027ipkjid4fs7